ATM controls c-Myc and DNA synthesis during postnatal thymocyte development through regulation of redox state

Free Radical Biology and Medicine

Volumn 41, Issue 4, 2006, Pages 640-648

  Yan, Mingshan ^a   Zhu, Chengming ^b   Liu, Na ^a   Jiang, Yuhong ^a   Scofield, Virginia L ^a   Riggs, Penny K ^a   Qiang, Wenan ^c   Lynn, William S ^a   Wong, Paul K Y ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

ATM; c Myc; Free radicals; Reactive oxygen species; Thymic lymphoma; Thymocyte development

Indexed keywords

ACETYLCYSTEINE; ATM PROTEIN; DNA; GLUTATHIONE; HYDROGEN PEROXIDE; MYC PROTEIN; PEROXIREDOXIN; TRANSCRIPTION FACTOR NRF2;

ANIMAL CELL; ARTICLE; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DEREGULATION; DNA SYNTHESIS; MOUSE; NONHUMAN; OXIDATION REDUCTION STATE; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYMOCYTE; UPREGULATION;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CELL CYCLE PROTEINS; DNA PRIMERS; DNA REPLICATION; DNA-BINDING PROTEINS; MICE; MICE, KNOCKOUT; NF-E2-RELATED FACTOR 2; OXIDATION-REDUCTION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-MYC; REACTIVE OXYGEN SPECIES; THYMUS GLAND; TUMOR SUPPRESSOR PROTEINS;

EID: 33746046363     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2006.05.008     Document Type: Article

References (53)

1. Lavin M.F. Radiosensitivity and oxidative signalling in ataxia telangiectasia: an update. Radiother. Oncol. 47 (1998) 113-123
2. Taylor A.M., Metcalfe J.A., Thick J., and Mak Y.F. Leukemia and lymphoma in ataxia telangiectasia. Blood 87 (1996) 423-438
3. Barlow C., Hirotsune S., Paylor R., Liyanage M., Eckhaus M., Collins F., Shiloh Y., Crawley J.N., Ried T., Tagle D., and Wynshaw-Boris A. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 86 (1996) 159-171
4. Xu Y., Ashley T., Brainerd E.E., Bronson R.T., Meyn M.S., and Baltimore D. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev. 10 (1996) 2411-2422
5. Yan M., Qiang W., Liu N., Shen J., Lynn W.S., and Wong P.K. The ataxia-telangiectasia gene product may modulate DNA turnover and control cell fate by regulating cellular redox in lymphocytes. FASEB J. 15 (2001) 1132-1138
6. -/- mice by dexamethasone. Cancer Res. 62 (2002) 5153-5157
7. Hoffman E.S., Passoni L., Crompton T., Leu T.M., Schatz D.G., Koff A., Owen M.J., and Hayday A.C. Productive T-cell receptor beta-chain gene rearrangement: coincident regulation of cell cycle and clonality during development in vivo. Genes Dev. 10 (1996) 948-962
8. Egerton M., Shortman K., and Scollay R. The kinetics of immature murine thymocyte development in vivo. Int. Immunol. 2 (1990) 501-507
9. - thymocytes: proliferation, renewal and differentiation of different cell subsets studied by DNA biosynthetic labeling and surface antigen detection. Eur. J. Immunol. 18 (1988) 1343-1350
10. Matei I.R., Guidos C.J., and Danska J.S. ATM-dependent DNA damage surveillance in T-cell development and leukemogenesis: the DSB connection. Immunol. Rev. 209 (2006) 142-158
11. Zaldumbide A., Carlotti F., Pognonec P., and Boulukos K.E. The role of the Ets2 transcription factor in the proliferation, maturation, and survival of mouse thymocytes. J. Immunol. 169 (2002) 4873-4881
12. Hayflick J., Seeburg P.H., Ohlsson R., Pfeifer-Ohlsson S., Watson D., Papas T., and Duesberg P.H. Nucleotide sequence of two overlapping myc-related genes in avian carcinoma virus OK10 and their relation to the myc genes of other viruses and the cell. Proc. Natl. Acad. Sci. USA 82 (1985) 2718-2722
13. Watson D.K., Reddy E.P., Duesberg P.H., and Papas T.S. Nucleotide sequence analysis of the chicken c-myc gene reveals homologous and unique coding regions by comparison with the transforming gene of avian myelocytomatosis virus MC29, delta gag-myc. Proc. Natl. Acad. Sci. USA 80 (1983) 2146-2150
14. Nesbit C.E., Tersak J.M., and Prochownik E.V. MYC oncogenes and human neoplastic disease. Oncogene 18 (1999) 3004-3016
15. Cole M.D., and McMahon S.B. The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation. Oncogene 18 (1999) 2916-2924
16. Qi Y., Gregory M.A., Li Z., Brousal J.P., West K., and Hann S.R. p19ARF directly and differentially controls the functions of c-Myc independently of p53. Nature 431 (2004) 712-717
17. Davis A.C., Wims M., Spotts G.D., Hann S.R., and Bradley A. A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev. 7 (1993) 671-682
18. Douglas N.C., Jacobs H., Bothwell A.L., and Hayday A.C. Defining the specific physiological requirements for c-Myc in T cell development. Nat. Immunol. 2 (2001) 307-315
19. Lynn W.S., and Wong P.K. Neuroimmunodegeneration: do neurons and T cells use common pathways for cell death?. FASEB J. 9 (1995) 1147-1156
20. Barzilai A., Rotman G., and Shiloh Y. ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage. DNA Repair (Amsterdam) 1 (2002) 3-25
21. Rotman G., and Shiloh Y. ATM: a mediator of multiple responses to genotoxic stress. Oncogene 18 (1999) 6135-6144
22. Takao N., Li Y., and Yamamoto K. Protective roles for ATM in cellular response to oxidative stress. FEBS Lett. 472 (2000) 133-136
23. Formichi P., Battisti C., Tripodi S.A., Tosi P., and Federico A. Apoptotic response and cell cycle transition in ataxia telangiectasia cells exposed to oxidative stress. Life Sci. 66 (2000) 1893-1903
24. Barlow C., Dennery P.A., Shigenaga M.K., Smith M.A., Morrow J.D., Roberts II L.J., Wynshaw-Boris A., and Levine R.L. Loss of the ataxia-telangiectasia gene product causes oxidative damage in target organs. Proc. Natl. Acad. Sci. USA 96 (1999) 9915-9919
25. Chen P., Peng C., Luff J., Spring K., Watters D., Bottle S., Furuya S., and Lavin M.F. Oxidative stress is responsible for deficient survival and dendritogenesis in Purkinje neurons from ataxia-telangiectasia mutated mutant mice. J. Neurosci. 23 (2003) 11453-11460
26. Ito K., Hirao A., Arai F., Matsuoka S., Takubo K., Hamaguchi I., Nomiyama K., Hosokawa K., Sakurada K., Nakagata N., Ikeda Y., Mak T.W., and Suda T. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 431 (2004) 997-1002
27. Liao M.J., Yin C., Barlow C., Wynshaw-Boris A., and van Dyke T. Atm is dispensable for p53 apoptosis and tumor suppression triggered by cell cycle dysfunction. Mol. Cell. Biol. 19 (1999) 3095-3102
28. Gibson U.E., Heid C.A., and Williams P.M. A novel method for real time quantitative RT-PCR. Genome Res. 6 (1996) 995-1001
29. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
30. Saha K., and Wong P.K. Rudimentary thymus of SCID mouse plays an important role in the development of retrovirus-induced neurologic disorders. Virology 195 (1993) 211-218
31. Qiang W., Cahill J.M., Liu J., Kuang X., Liu N., Scofield V.L., Voorhees J.R., Reid A.J., Yan M., Lynn W.S., and Wong P.K. Activation of transcription factor Nrf-2 and its downstream targets in response to Moloney murine leukemia virus ts1-induced thiol depletion and oxidative stress in astrocytes. J. Virol. 78 (2004) 11926-11938
32. Shrieve D.C., Bump E.A., and Rice G.C. Heterogeneity of cellular glutathione among cells derived from a murine fibrosarcoma or a human renal cell carcinoma detected by flow cytometric analysis. J. Biol. Chem. 263 (1988) 14107-14114
33. Pusapati R.V., Rounbehler R.J., Hong S., Powers J.T., Yan M., Kiguchi K., McArthur M.J., Wong P.K., and Johnson D.G. ATM promotes apoptosis and suppresses tumorigenesis in response to Myc. Proc. Natl. Acad. Sci. USA 103 (2006) 1446-1451
34. Finkel T. Oxygen radicals and signaling. Curr. Opin. Cell Biol. 10 (1998) 248-253
35. Moon E.Y., Han Y.H., Lee D.S., Han Y.M., and Yu D.Y. Reactive oxygen species induced by the deletion of peroxiredoxin II (PrxII) increases the number of thymocytes resulting in the enlargement of PrxII-null thymus. Eur. J. Immunol. 34 (2004) 2119-2128
36. Moi P., Chan K., Asunis I., Cao A., and Kan Y.W. Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc. Natl. Acad. Sci. USA 91 (1994) 9926-9930
37. Shih A.Y., Johnson D.A., Wong G., Kraft A.D., Jiang L., Erb H., Johnson J.A., and Murphy T.H. Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress. J. Neurosci. 23 (2003) 3394-3406
38. Rhee S.G., Chae H.Z., and Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic. Biol. Med. 38 (2005) 1543-1552
39. Lee J.M., Calkins M.J., Chan K., Kan Y.W., and Johnson J.A. Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. J. Biol. Chem. 278 (2003) 12029-12038
40. Mu Z.M., Yin X.Y., and Prochownik E.V. Pag, a putative tumor suppressor, interacts with the Myc Box II domain of c-Myc and selectively alters its biological function and target gene expression. J. Biol. Chem. 277 (2002) 43175-43184
41. Egler R.A., Fernandes E., Rothermund K., Sereika S., de Souza-Pinto N., Jaruga P., Dizdaroglu M., and Prochownik E.V. Regulation of reactive oxygen species, DNA damage, and c-Myc function by peroxiredoxin 1. Oncogene 24 (2005) 8038-8050
42. Lynn W.S., and Wong P.K. Possible control of cell death pathways in ataxia telangiectasia: a case report. Neuroimmunomodulation 4 (1997) 277-284
43. Soccio M., Toniato E., Evangelista V., Carluccio M., and De Caterina R. Oxidative stress and cardiovascular risk: the role of vascular NAD(P)H oxidase and its genetic variants. Eur. J. Clin. Invest. 35 (2005) 305-314
44. Rueckschloss U., Galle J., Holtz J., Zerkowski H.R., and Morawietz H. Induction of NAD(P)H oxidase by oxidized low-density lipoprotein in human endothelial cells: antioxidative potential of hydroxymethylglutaryl coenzyme A reductase inhibitor therapy. Circulation 104 (2001) 1767-1772
45. Sauer H., Wartenberg M., and Hescheler J. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell. Physiol. Biochem. 11 (2001) 173-186
46. Hou R.C., Wu C.C., Huang J.R., Chen Y.S., and Jeng K.C. Oxidative toxicity in BV-2 microglia cells: sesamolin neuroprotection of H2O2 injury involving activation of p38 mitogen-activated protein kinase. Ann. N. Y. Acad. Sci. 1042 (2005) 279-285
47. Kamata H., Honda S., Maeda S., Chang L., Hirata H., and Karin M. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120 (2005) 649-661
48. Sulciner D.J., Irani K., Yu Z.X., Ferrans V.J., Goldschmidt-Clermont P., and Finkel T. rac1 regulates a cytokine-stimulated, redox-dependent pathway necessary for NF-kappaB activation. Mol. Cell. Biol. 16 (1996) 7115-7121
49. Bubici C., Papa S., Pham C.G., Zazzeroni F., and Franzoso G. The NF-kappaB-mediated control of ROS and JNK signaling. Histol. Histopathol. 21 (2006) 69-80
50. Kim M.H., Cho H.S., Jung M., Hong M.H., Lee S.K., Shin B.A., Ahn B.W., and Jung Y.D. Extracellular signal-regulated kinase and AP-1 pathways are involved in reactive oxygen species-induced urokinase plasminogen activator receptor expression in human gastric cancer cells. Int. J. Oncol. 26 (2005) 1669-1674
51. Benassi B., Fanciulli M., Fiorentino F., Porrello A., Chiorino G., Loda M., Zupi G., and Biroccio A. c-Myc phosphorylation is required for cellular response to oxidative stress. Mol. Cell 21 (2006) 509-519
52. Peus D., Vasa R.A., Beyerle A., Meves A., Krautmacher C., and Pittelkow M.R. UVB activates ERK1/2 and p38 signaling pathways via reactive oxygen species in cultured keratinocytes. J. Invest. Dermatol. 112 (1999) 751-756
53. Liu N., Stoica G., Yan M., Scofield V.L., Qiang W., Lynn W.S., and Wong P.K. ATM deficiency induces oxidative stress and endoplasmic reticulum stress in astrocytes. Lab. Invest. 85 (2005) 1471-1480